These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38692867)
1. From Glycolysis to Viral Defense: The Multifaceted Impact of Glycolytic Enzymes on Human Immunodeficiency Virus Type 1 Replication. Kishimoto N; Misumi S Biol Pharm Bull; 2024; 47(5):905-911. PubMed ID: 38692867 [TBL] [Abstract][Full Text] [Related]
2. Glucose-dependent aerobic glycolysis contributes to recruiting viral components into HIV-1 particles to maintain infectivity. Kishimoto N; Yamamoto K; Abe T; Yasuoka N; Takamune N; Misumi S Biochem Biophys Res Commun; 2021 Apr; 549():187-193. PubMed ID: 33676187 [TBL] [Abstract][Full Text] [Related]
3. Alpha-enolase in viral target cells suppresses the human immunodeficiency virus type 1 integration. Kishimoto N; Yamamoto K; Iga N; Kirihara C; Abe T; Takamune N; Misumi S Retrovirology; 2020 Sep; 17(1):31. PubMed ID: 32917235 [TBL] [Abstract][Full Text] [Related]
4. Glyceraldehyde-3-Phosphate Dehydrogenase Restricted in Cytoplasmic Location by Viral GP5 Facilitates Porcine Reproductive and Respiratory Syndrome Virus Replication via Its Glycolytic Activity. Liu X; Liu X; Bai J; Gao Y; Song Z; Nauwynck H; Wang X; Yang Y; Jiang P J Virol; 2021 Aug; 95(18):e0021021. PubMed ID: 34160254 [TBL] [Abstract][Full Text] [Related]
5. Moonlighting glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is required for efficient hepatitis C virus and dengue virus infections in human Huh-7.5.1 cells. Raj M; Langley M; McArthur SJ; Jean F J Gen Virol; 2017 May; 98(5):977-991. PubMed ID: 28548037 [TBL] [Abstract][Full Text] [Related]
7. HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection. Jiang G; Santos Rocha C; Hirao LA; Mendes EA; Tang Y; Thompson GR; Wong JK; Dandekar S mBio; 2017 May; 8(3):. PubMed ID: 28465428 [TBL] [Abstract][Full Text] [Related]
8. HIV-1 pathogenicity and virion production are dependent on the metabolic phenotype of activated CD4+ T cells. Hegedus A; Kavanagh Williamson M; Huthoff H Retrovirology; 2014 Nov; 11():98. PubMed ID: 25421745 [TBL] [Abstract][Full Text] [Related]
9. Co-opting the fermentation pathway for tombusvirus replication: Compartmentalization of cellular metabolic pathways for rapid ATP generation. Lin W; Liu Y; Molho M; Zhang S; Wang L; Xie L; Nagy PD PLoS Pathog; 2019 Oct; 15(10):e1008092. PubMed ID: 31648290 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of Glucose Uptake and Hexokinase Activity of Primary Human CD4+ T Cells in Response to Infection with HIV-1. Kavanagh Williamson M; Coombes N; Juszczak F; Athanasopoulos M; Khan MB; Eykyn TR; Srenathan U; Taams LS; Dias Zeidler J; Da Poian AT; Huthoff H Viruses; 2018 Mar; 10(3):. PubMed ID: 29518929 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 envelope glycoprotein stimulates viral transcription and increases the infectivity of the progeny virus through the manipulation of cellular machinery. Ran X; Ao Z; Trajtman A; Xu W; Kobinger G; Keynan Y; Yao X Sci Rep; 2017 Aug; 7(1):9487. PubMed ID: 28842659 [TBL] [Abstract][Full Text] [Related]
12. Specific Deubiquitinating Enzymes Promote Host Restriction Factors Against HIV/SIV Viruses. Gao W; Rui Y; Li G; Zhai C; Su J; Liu H; Zheng W; Zheng B; Zhang W; Yang Y; Hua S; Yu X Front Immunol; 2021; 12():740713. PubMed ID: 34630422 [TBL] [Abstract][Full Text] [Related]
13. Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication. Palmer BE; Boritz E; Blyveis N; Wilson CC J Virol; 2002 Jun; 76(12):5925-36. PubMed ID: 12021325 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins. Schang LM; Bantly A; Knockaert M; Shaheen F; Meijer L; Malim MH; Gray NS; Schaffer PA J Virol; 2002 Aug; 76(15):7874-82. PubMed ID: 12097601 [TBL] [Abstract][Full Text] [Related]
15. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Pierson T; McArthur J; Siliciano RF Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072 [TBL] [Abstract][Full Text] [Related]
16. Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure. Siliciano JD; Siliciano RF J Infect Dis; 2021 Feb; 223(12 Suppl 2):13-21. PubMed ID: 33586775 [TBL] [Abstract][Full Text] [Related]
17. Disruption of Type I Interferon Induction by HIV Infection of T Cells. Sanchez DJ; Miranda D; Marsden MD; Dizon TM; Bontemps JR; Davila SJ; Del Mundo LE; Ha T; Senaati A; Zack JA; Cheng G PLoS One; 2015; 10(9):e0137951. PubMed ID: 26375588 [TBL] [Abstract][Full Text] [Related]
18. Elevated glycolysis imparts functional ability to CD8 Rahman AN; Liu J; Mujib S; Kidane S; Ali A; Szep S; Han C; Bonner P; Parsons M; Benko E; Kovacs C; Yue FY; Ostrowski M Life Sci Alliance; 2021 Nov; 4(11):. PubMed ID: 34548381 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 translation and its regulation by cellular factors PKR and PACT. Burugu S; Daher A; Meurs EF; Gatignol A Virus Res; 2014 Nov; 193():65-77. PubMed ID: 25064266 [TBL] [Abstract][Full Text] [Related]
20. Interplay between HIV-1 and Toll-like receptors in human myeloid cells: friend or foe in HIV-1 pathogenesis? Donninelli G; Gessani S; Del CornĂ² M J Leukoc Biol; 2016 Jan; 99(1):97-105. PubMed ID: 26307548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]